Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Smal Cell Lung Cancer)
This study is currently recruiting participants.
Verified May 2013 by Bayer
Study NCT01573338
Information provided by Bayer
First Received on April 5, 2012.
Last Updated on May 8, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
